• info@treatmentingermany.de
  • +49 1577 8577 507
×

What is Chronic Inflammatory Demyelinating Polyneuropathy (CIDP):

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder that affects the peripheral nerves. In CIDP, the body's immune system mistakenly attacks the myelin sheath, the protective covering of the nerves, leading to inflammation and damage.

This damage disrupts the normal functioning of the nerves, causing weakness, numbness, tingling, and pain in the arms and legs. CIDP is considered a chronic condition, meaning it can persist over a long period and may require ongoing management.

Side effects of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP):

The symptoms of Chronic Inflammatory Demyelinating Polyneuropathy can vary from person to person and may include:

  • Muscle weakness, especially in the legs and arms.
  • Numbness or tingling sensations, often starting in the feet and hands and spreading upwards.
  • Difficulty with balance and coordination.
  • Fatigue.
  • Difficulty walking or performing tasks that require fine motor skills.
  • Pain, ranging from mild discomfort to severe, stabbing sensations.

These symptoms can significantly impact a person's quality of life, making everyday activities challenging.

How is Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) diagnosed?

Diagnosing Chronic Inflammatory Demyelinating Polyneuropathy can be challenging because its symptoms overlap with those of other neurological disorders. However, several tests can aid in the diagnosis, including:

  • Nerve conduction studies: These tests measure how well electrical signals travel along the nerves, helping to identify areas of nerve damage.
  • Electromyography (EMG): EMG evaluates the electrical activity of muscles, which can indicate nerve dysfunction.
  • Blood tests: Blood tests can help rule out other conditions that may mimic CIDP.
  • Lumbar puncture (spinal tap): This test involves collecting a sample of cerebrospinal fluid to look for signs of inflammation or abnormal antibodies.
  • Imaging tests: MRI scans may be used to rule out other causes of nerve damage, such as tumors or spinal cord compression.

A comprehensive evaluation, including a thorough medical history and neurological examination, is crucial for an accurate diagnosis.

Potential treatments of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP):

Treatment for Chronic Inflammatory Demyelinating Polyneuropathy aims to reduce inflammation, manage symptoms, and prevent further nerve damage. In Germany, the following treatments may be considered:

  • Intravenous immunoglobulin (IVIG) therapy: This involves infusions of antibodies collected from donated blood, which can help regulate the immune system and reduce inflammation.
  • Corticosteroids: Steroid medications, such as prednisone, may be prescribed to suppress the immune response and decrease inflammation.
  • Plasma exchange (plasmapheresis): This procedure involves removing blood plasma, which contains harmful antibodies, and replacing it with donor plasma or a plasma substitute.
  • Immunosuppressive medications: Drugs like azathioprine, rituximab, or cyclophosphamide may be used to suppress the immune system and reduce inflammation in severe cases.
  • Physical therapy: Rehabilitation exercises and physical therapy can help improve muscle strength, mobility, and coordination, enhancing overall function and quality of life.


👉
 Contact us for further information and receive a complimentary consultation.